NOD2

From WikiMD's WELLNESSPEDIA

NOD2 is a protein that in humans is encoded by the NOD2 gene. It is a member of the NOD-like receptor (NLR) family, which plays a crucial role in the immune system by recognizing molecules derived from pathogens and initiating an immune response.

Function[edit]

NOD2 is an intracellular pattern recognition receptor that can detect bacterial peptidoglycan, specifically muramyl dipeptide (MDP). Upon recognition of MDP, NOD2 activates the nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) pathway, leading to the production of pro-inflammatory cytokines and chemokines. This process is essential for the body's defense against bacterial infections.

Clinical significance[edit]

Mutations in the NOD2 gene are associated with several diseases, including Crohn's disease, Blau syndrome, and early-onset sarcoidosis. These diseases are characterized by chronic inflammation, suggesting a role for NOD2 in the regulation of inflammatory responses.

Crohn's disease[edit]

In Crohn's disease, certain mutations in the NOD2 gene increase the risk of developing the disease. These mutations result in a NOD2 protein that is less able to recognize MDP, leading to a reduced immune response to bacteria in the gut. This may contribute to the chronic inflammation seen in Crohn's disease.

Blau syndrome[edit]

Blau syndrome is a rare genetic disorder characterized by granulomatous arthritis, uveitis, and dermatitis. It is caused by mutations in the NOD2 gene that result in a constitutively active NOD2 protein, leading to continuous activation of the NF-κB pathway and chronic inflammation.

Sarcoidosis[edit]

Early-onset sarcoidosis is a rare form of sarcoidosis that begins in childhood. Like Blau syndrome, it is associated with mutations in the NOD2 gene that result in a constitutively active NOD2 protein.

See also[edit]

References[edit]



Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.